advances in antibody-drug conjugates (adcs) development & preclinical model
Published 1 month ago • 7 plays • Length 52:37Download video MP4
Download video MP3
Similar videos
-
1:15
jk06, a biparatopic adc in preclinical development
-
3:33
what are antibody-drug conjugates (adcs)?
-
16:46
what are antibody drug conjugates (adcs)? 👀 the newest cancer treatment breakthrough – explained!
-
1:44
what are antibody-drug conjugates and how do they work against cancer?
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
24:48
challenges and advances in antibody-drug conjugates.
-
10:18
the basic knowledge of adc - creative biolabs
-
11:49
how do monoclonal antibodies work? rituximab, infliximab, adalimumab and others
-
5:57
characterization of antibody-drug conjugates (adc)
-
17:37
cmc considerations for commercial-ready adc manufacturing processes to enable accelerated timelines
-
30:06
the abcs of adcs: ovarian cancer and antibody drug conjugates
-
7:12
brief introduction of antibody drug conjugates - boc sciences
-
17:47
biomissiles adc drugs
-
9:24
the development of a next generation antibody drug conjugate adc
-
54:24
model-based strategy to guide the choice of clinical doses for antibody–drug conjugates
-
30:15
manufacturing concepts for antibody-drug conjugates | webinar
-
2:22
how do adc technologies and services speed up the manufacturing process?
-
33:51
advances in mass spectrometry for the analysis and bioanalysis of antibody drug conjugates
-
7:29
antibody-drug conjugates - where are we going?
-
41:25
simple and effective tools for antibody-drug conjugate screening and characterization
-
38:07
antibody-drug conjugates (adcs): current research and overcoming challenges - webinar playback
-
1:35
challenges in development and clinical use of adcs for lung cancer